Cited by 975HIV-related health complications and treatmentsHIV/AIDS Research and InterventionsCardiovascular Health and Risk Factors

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis

Open access

Shah, Anoop S.V., Stelzle, Dominik, Lee, Kuan Ken, Beck, Eduard J., Alam, Shirjel, Clifford, Sarah, Longenecker, Chris T., Strachan, Fiona, Bagchi, Shashwatee, Whiteley, William, Rajagopalan, Sanjay, Kottilil, Shyamasundaran, Nair, Harish, Newby, David E., McAllister, David A., Mills, Nicholas L.·2018·Circulation

DOI 10.1161/circulationaha.117.033369PMC PMC6221183

Open this paper in CoChat — free account

Abstract

Background: With advances in antiretroviral therapy, most deaths in people with HIV are now attributable to noncommunicable illnesses, especially cardiovascular disease. We determine the association between HIV and cardiovascular disease, and estimate the national, regional, and global burden of cardiovascular disease attributable to HIV. Methods: We conducted a systematic review across 5 databases from inception to August 2016 for longitudinal studies of cardiovascular disease in HIV infection. A random-effects meta-analysis across 80 studies was used to derive the pooled rate and risk of cardiovascular disease in people living with HIV. We then estimated the temporal changes in the population-attributable fraction and disability-adjusted life-years (DALYs) from HIV-associated cardiovascular disease from 1990 to 2015 at a regional and global level. National cardiovascular DALYs associated with HIV for 2015 were derived for 154 of the 193 United Nations member states. The main outcome measure was the pooled estimate of the rate and risk of cardiovascular disease in people living with HIV and the national, regional, and global estimates of DALYs from cardiovascular disease associated with HIV. Results: In 793 635 people living with HIV and a total follow-up of 3.5 million person-years, the crude rate of cardiovascular disease was 61.8 (95% CI, 45.8–83.4) per 10 000 person-years. In comparison with individuals without HIV, the risk ratio for cardiovascular disease was 2.16 (95% CI, 1.68–2.77). Over the past 26 years, the global population–attributable fraction from cardiovascular disease attributable to HIV increased from 0.36% (95% CI, 0.21%–0.56%) to 0.92% (95% CI, 0.55%–1.41%), and DALYs increased from 0.74 (95% CI, 0.44–1.16) to 2.57 (95% CI, 1.53–3.92) million. There was marked regional variation with most DALYs lost in sub-Saharan Africa (0.87 million, 95% CI, 0.43–1.70) and the Asia Pacific (0.39 million, 95% CI, 0.23–0.62) regions. The highest population-attributable fraction and burden were observed in Swaziland, Botswana, and Lesotho. Conclusions: People living with HIV are twice as likely to develop cardiovascular disease. The global burden of HIV-associated cardiovascular disease has tripled over the past 2 decades and is now responsible for 2.6 million DALYs per annum with the greatest impact in sub-Saharan Africa and the Asia Pacific regions. Clinical Trial Registration: URL: https://www.crd.york.ac.uk/prospero . Unique identifier: CRD42016048257.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.117.033369

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381

Show all 60 references

Sorted by citations

Items 201–300 of 974

Monocytes from men living with HIV exhibit heightened atherogenic potential despite long-term viral suppression with antiretroviral therapy
Angelovich, T. A., Trevillyan, J. M., Hoy, J., Wong, M. E., Agius, P. A., Hearps, A. C., & Jaworowski, A. (2019) · AIDS · doi:10.1097/qad.0000000000002460 · Cited by 16
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation
Montrucchio, C., Nicolò, A. D., d’Ettorre, G., D’Ascenzo, F., Lazzaro, A., Tettoni, M. C., D’Avolio, A., Bonora, S., Celani, L., Perri, G. D., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105908 · Cited by 16
Understanding constraints on integrated care for people with HIV and multimorbid cardiovascular conditions: an application of the Theoretical Domains Framework
Schexnayder, J. K., Longenecker, C. T., Muiruri, C., Bosworth, H. B., Gebhardt, D., Gonzales, S. E., Hanson, J. E., Hileman, C. O., Okeke, N. L., Sico, I. P., et al. (2021) · Implementation Science Communications · doi:10.1186/s43058-021-00114-z · Cited by 16
Self-citation
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy: Republication
Shah, S., & Hill, A. M. (2021) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000671 · Cited by 16
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period
Boccara, F., Caramelli, B., Calmy, A., Kumar, P., López, J. A. G., Bray, S., Cyrille, M., & Rosenson, R. S. (2022) · AIDS · doi:10.1097/qad.0000000000003175 · Cited by 16
Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats
Everson, F., Genis, A., Ogundipe, T. R., Boever, P. D., Goswami, N., Lochner, A., Blackhurst, D., & Strijdom, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208537 · Cited by 16
Cardiorespiratory fitness is associated with inflammation and physical activity in HIV+ adults
Webel, A. R., Jenkins, T. L., Vest, M., Oliveira, V. H. F., Longenecker, C. T., Liu, J., Currie, J., Sattar, A., & Josephson, R. (2019) · AIDS · doi:10.1097/qad.0000000000002154 · Cited by 16
Self-citation
HIV-related cardiovascular disease: any role for high-density lipoproteins?
Hudson, P., Woudberg, N. J., Kamau, F., Strijdom, H., Frias, M. A., & Lecour, S. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00445.2020 · Cited by 15
At the heart of the matter: Cardiovascular health challenges among incarcerated women
Grammatikopoulou, M. G., Lampropoulou, M., Milapidou, M., & Goulis, D. G. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.05.002 · Cited by 15
Factors affecting statin uptake among people living with HIV: primary care provider perspectives
Ober, A. J., Takada, S., Zajdman, D., Todd, I., Horwich, T. B., Anderson, A., Wali, S., & Ladapo, J. A. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01563-0 · Cited by 15
Prevalence, severity, and risk factors of disability among adults living with HIV accessing routine outpatient HIV care in London, United Kingdom (UK): A cross-sectional self-report study
Brown, D. A., O’Brien, K. K., Harding, R., Sedgwick, P. M., Nelson, M. R., Boffito, M., & Lewko, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267271 · Cited by 16
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk
Fitch, K. V., McCallum, S., Erlandson, K. M., Overton, E. T., Zanni, M. V., Fichtenbaum, C. J., Aberg, J. A., Fulda, E. S., Kileel, E. M., Moran, L. E., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003344 · Cited by 15
Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV
Saloner, R., Sun-Suslow, N., Morgan, E. E., Lobo, J. D., Cherner, M., Ellis, R. J., Heaton, R. K., Grant, I., Letendre, S. L., & Iudicello, J. E. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100560 · Cited by 15
The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV
Peters, B. A., Burk, R. D., Kaplan, R. C., & Qi, Q. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00648-y · Cited by 16
Prevalence and incidence of stroke among people with HIV
Du, M., Wang, Y., Qin, C., Mi, D., Liu, M., & Liu, J. (2023) · AIDS · doi:10.1097/qad.0000000000003632 · Cited by 15
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection
Zisman, E., Hossain, M. B., Funderburg, N., Christenson, R. H., Jeudy, J. J., Burrowes, S. A. B., Hays, A. G., George, N., Freeman, M. L., Rebuck, H., et al. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.02.003 · Cited by 16
Self-citation
Weight Gain in HIV Adults Receiving Antiretroviral Treatment: Current Knowledge and Future Perspectives
Markakis, K., Tsachouridou, Ο., Georgianou, E., Pilalas, D., Nanoudis, S., & Metallidis, S. (2024) · Life · doi:10.3390/life14111367 · Cited by 16
A Mixed Methods, Observational Investigation of Physical Activity, Exercise, and Diet Among Older Ugandans Living With and Without Chronic HIV Infection
Wright, C. H., Longenecker, C. T., Nazzindah, R., Kityo, C. M., Najjuuko, T., Taylor, K., Rentrope, C. R., & Webel, A. R. (2020) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000221 · Cited by 14
Self-citation
Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Schoepf, I. C., Thorball, C. W., Ledergerber, B., Engel, T., Raffenberg, M., Kootstra, N. A., Reiss, P., Hasse, B. K., Marzolini, C., Thurnheer, C., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab521 · Cited by 15
Hypertension Care for People With HIV in Tanzania: Provider Perspectives and Opportunities for Improvement
Manavalan, P., Wanda, L., Galson, S. W., Thielman, N. M., Mmbaga, B. T., & Watt, M. H. (2021) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/23259582211052399 · Cited by 15
Arterial Stiffness in a Cohort of Young People Living With Perinatal HIV and HIV Negative Young People in England
Mellin, J., Prevost, M. L., Kenny, J. M., Sturgeon, K., Thompson, L. C., Foster, C., Kessler, H. H., Goswami, N., Klein, N. J., Judd, A., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.821568 · Cited by 15
Integrating hypertension and HIV care in Namibia: A quality improvement collaborative approach
Basenero, A., Neidel, J., Ikeda, D. J., Ashivudhi, H., Mpariwa, S., Kamangu, J., Kakubu, M. A. M., Hans, L., Mutandi, G., Jed, S. L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272727 · Cited by 16
Cardiovascular disease among people living with HIV in Brazil
Boettiger, D. C., Escuder, M. M. L., Law, M. G., Veloso, V. G., Souza, R. D. A., Ikeda, M. L. R., de Alencastro, P. R., Tupinambás, U., Brites, C. R., Grinsztejn, B. G. J., et al. (2020) · Tropical Medicine & International Health · doi:10.1111/tmi.13405 · Cited by 15
[68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging
Lawal, I. O., Popoola, G. O., Mahapane, J., Kaufmann, J., Davis, C., Ndlovu, H., Maserumule, L. C., Mokoala, K. M. G., Bouterfa, H., Wester, H., et al. (2020) · Biomolecules · doi:10.3390/biom10121629 · Cited by 15
Randomized parallel-group pilot trial (Best foods for your heart) comparing the effects of a Mediterranean Portfolio diet with a low saturated fat diet on HIV dyslipidemia
Stradling, C., Thomas, G. N., Hemming, K., Taylor, S. R., & Taheri, S. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.08.038 · Cited by 15
Prevalence and Correlates of Ischemic ECG Findings among Adults With and Without HIV in Tanzania
Prattipati, S., Sakita, F. M., Tarimo, T. G., Kweka, G. L., Mlangi, J. J., Maro, A. V., Coaxum, L. A., Galson, S. W., Limkakeng, A. T., Rugakingira, A., et al. (2022) · Global Heart · doi:10.5334/gh.1127 · Cited by 14
Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations
Karády, J., Lu, M. T., Bergström, G. M. L., Mayrhofer, T., Taron, J., Foldyna, B., Paradis, K., McCallum, S., Aberg, J. A., Currier, J. S., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100968 · Cited by 14
Clinical profile, anatomical features and long‐term outcome of acute coronary syndromes in human immunodeficiency virus‐infected patients
Postigo, A., Díez‐Delhoyo, F., Devesa, C., Bruña, V., Clavero‐Olmos, M., Vicent, L., Juárez, M., Sousa, I., Fernández‐Avilés, F., & Martínez‐Sellés, M. (2020) · Internal Medicine Journal · doi:10.1111/imj.14744 · Cited by 14
Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir
Knudsen, A. D., Krebs-Demmer, L., Bjørge, N. I. D., Elming, M. B., Gelpi, M., Sigvardsen, P. E., Lebech, A., Fuchs, A., Kühl, J. T., Køber, L., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa057 · Cited by 15
An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa
Peprah, E. K., Armstrong-Hough, M. J., Cook, S., Mukasa, B., Taylor, J. Y., Xu, H., Chang, L., Gyamfi, J., Ryan, N., Ojo, T., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063111 · Cited by 14
Cardiovascular disease and prevention among people living with HIV in South Florida
Pyarali, F. F., Iordanov, R. B., Ebner, B., Grant, J. K., Vincent, L. T., Toirac, A., Haque, T., Zablah, G. J., Kapoor, K., Powell, A. R., et al. (2021) · Medicine · doi:10.1097/md.0000000000026631 · Cited by 14
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years
Schoepf, I. C., Thorball, C. W., Ledergerber, B., Kootstra, N. A., Reiss, P., Raffenberg, M., Engel, T., Braun, D. L., Hasse, B. K., Thurnheer, C., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab603 · Cited by 14
Relationship of Subcutaneous Adipose Tissue Inflammation–Related Gene Expression With Ectopic Lipid Deposition in Persons With HIV
Bailin, S. S., Gabriel, C. L., Fan, R., Ye, F., Nair, S., Terry, J. G., Carr, J. J., Silver, H. J., Wanjalla, C. N., Mashayekhi, M., et al. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002926 · Cited by 13
Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study
Piconi, S., Foschi, A., Malagoli, A., Carli, F., Zona, S., Milić, J., Ricci, E. D., Rizzardini, G., & Guaraldi, G. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz227 · Cited by 14
Myocardial Inflammation and Edema in People Living With Human Immunodeficiency Virus
Menacho, K., Seraphim, A., Ramírez, S., Falcon, L., Bhuva, A., Alave, J., Banda, C., Mejía, F., Salazar, D., Putri, A., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.12.005 · Cited by 14
HIV and Cardiovascular Disease — An Ounce of Prevention
Freiberg, M. S. (2023) · New England Journal of Medicine · doi:10.1056/nejme2306782 · Cited by 14
Human Immunodeficiency Virus and Cardiac End-Organ Damage in Women: Findings From an Echocardiographic Study Across the United States
Shitole, S. G., Lazar, J., Taub, C. C., Furlani, A. C., Konkle‐Parker, D. J., Dionne‐Odom, J., Fischl, M. A., Ofotokun, I., Adimora, A. A., Topper, E. F., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac795 · Cited by 13
Ideal Cardiovascular Health: Distribution, Determinants and Relationship with Health Status among People Living with HIV in Urban Tanzania
Ottaru, T. A., Kwesigabo, G., Butt, Z. A., Rivera, A. S., Chillo, P., Siril, H. N., Hirschhorn, L. R., Feinstein, M. J., & Hawkins, C. (2022) · Global Heart · doi:10.5334/gh.1157 · Cited by 13
Clinical Characteristics and Outcomes of Patients Hospitalized With COVID-19 During the First 4 Waves in Zambia
Minchella, P. A., Chanda, D. M., Hines, J. Z., Fwoloshi, S., Itoh, M., Kampamba, D., Chirwa, R., Sivile, S., Zyambo, K., Agolory, S. G., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.46152 · Cited by 13
An efficient approach to estimate the risk of coronary artery disease for people living with HIV using machine-learning-based retinal image analysis
Lui, G. C.-Y., Leung, H. S., Lee, J., Wong, C. K., Li, X., Ho, M., Wong, V., Li, T., Ho, T., Chan, Y. Y., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281701 · Cited by 13
Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV
Wise, J. M., Jackson, E. A., Kempf, M.-C., Oates, G. R., Wang, Z., Overton, E. T., Siddiqui, M., Woodward, M., Rosenson, R. S., & Muntner, P. (2023) · AIDS · doi:10.1097/qad.0000000000003592 · Cited by 13
Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)—Results From the MIRACLE HIV Study
Srinivasa, S., Walpert, A. R., Thomas, T. S., Huck, D. M., Jerosch‐Herold, M., Islam, S., Lu, M. T., Burdo, T. H., deFilippi, C. R., Dunderdale, C. N., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad310 · Cited by 13
Changes in subcutaneous white adipose tissue cellular composition and molecular programs underlie glucose intolerance in persons with HIV
Bailin, S. S., Kropski, J. A., Gangula, R., Hannah, L., Simmons, J. D., Mashayekhi, M., Ye, F., Fan, R., Mallal, S. A., Warren, C. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152003 · Cited by 13
The Impact of Contemporary Antiretroviral Drugs on Atherosclerosis and Its Complications in People Living With HIV: A Systematic Review
Vemulapalli, A. C., Elias, A. A., Yerramsetti, M. D., Olanisa, O. O., Jain, P., Khan, Q. S., & Butt, S. R. (2023) · Cureus · doi:10.7759/cureus.47730 · Cited by 13
Dyslipidemia among HIV-infected patients in Ethiopia: a systematic review and meta-analysis
Mohammed, O., Alemayehu, E., Debash, H., Belete, M. A., Gedefie, A., Tilahun, M., Ebrahim, H., & Gebretsadik, D. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08910-9 · Cited by 13
Circulating GDF-15: a biomarker for metabolic dysregulation and aging in people living with HIV
Wang, L., Zhao, J., Schank, M., Hill, A. C., Banik, P., Zhang, Y. Q., Wu, X. Y., Lightner, J., Ning, S., Gazzar, M. E., et al. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1414866 · Cited by 13
Understanding barriers and facilitators to integrated HIV and hypertension care in South Africa
Johnson, L. C. M., Khan, S. H., Ali, M. K., Galaviz, K. I., Waseem, F., Ordóñez, C. E., Siedner, M. J., Nyatela, A., Marconi, V. C., & Lalla‐Edward, S. T. (2024) · Implementation Science Communications · doi:10.1186/s43058-024-00625-5 · Cited by 13
Investigating the research trajectory and future trends of immune disorders in diabetes cardiovascular complications: A bibliometric analysis over the past decade based on big data
Li, X., Zhou, X., Huang, T., Jiang, Y., Wan, H., Zhang, D., Ling, J., Wu, Y., Liu, X., Yang, P., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102473 · Cited by 13
Integrating hypertension detection and management in HIV care in South Africa: protocol for a stepped-wedged cluster randomized effectiveness-implementation hybrid trial
Galaviz, K. I., Patel, S. A., Siedner, M. J., Goss, C. W., Gumede, S. B., Johnson, L. C. M., Ordóñez, C. E., Laxy, M., Klipstein‐Grobusch, K., Heine, M., et al. (2024) · Implementation Science Communications · doi:10.1186/s43058-024-00640-6 · Cited by 13
Subclinical Atherosclerosis Imaging in People Living with HIV
Schoepf, I. C., Buechel, R. R., Kovari, H., Hammoud, D. A., & TARR, P. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081125 · Cited by 13
Human Immunodeficiency Virus Infection and Risk of Heart Failure Rehospitalizations
Brouch, D. T., Tashtish, N., Felice, C. D., Longenecker, C. T., & Al-Kindi, S. G. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.034 · Cited by 13
Self-citation
Impact of Heroin and HIV on Gut Integrity and Immune Activation
Hileman, C. O., Bowman, E. R., Gabriel, J., Kettelhut, A., Labbato, D., Smith, C., Avery, A., Parran, T., Funderburg, N., & McComsey, G. A. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002893 · Cited by 13
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
Chammartin, F., Darling, K., Abela, I. A., Battegay, M., Furrer, H., Calmy, A., Bernasconi, E., Schmid, P., Hoffmann, M., Bucher, H. C., et al. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003094 · Cited by 13
The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI
Liu, S., Wei, B., Liang, W. H., Chen, T., Deng, L., Zhao, M., & Wan, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1161503 · Cited by 13
Kidney Transplantation in Patients with HIV
Sawinski, D. L. (2020) · Kidney360 · doi:10.34067/kid.0002112020 · Cited by 14
Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study
Chamie, G., Hickey, M. D., Kwarisiima, D., Ayieko, J., Kamya, M. R., & Havlir, D. V. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00500-7 · Cited by 13
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis
Fichtenbaum, C. J., Malvestutto, C., Watanabe, M., Smith, E. D., Ribaudo, H. J., McCallum, S., Fitch, K. V., Currier, J. S., Diggs, M. R., Chu, S. M., et al. (2025) · The Lancet HIV · doi:10.1016/s2352-3018(25)00043-8 · Cited by 12
Relationship between sleep disorders, HIV status and cardiovascular risk: cross-sectional study of long-haul truck drivers from Southern Africa
Roche, J., Vos, A. G., Lalla‐Edward, S. T., Venter, F., & Scheuermaier, K. D. (2021) · Occupational and Environmental Medicine · doi:10.1136/oemed-2020-107208 · Cited by 10
Molecular Linkage between Immune System Disorders and Atherosclerosis
Napiórkowska-Baran, K., Schmidt, O., Szymczak, B., Lubański, J., Doligalska, A., & Bartuzi, Z. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110552 · Cited by 14
Weight Gain and Antiretroviral Therapy
Bailin, S. S., & Koethe, J. R. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.04.005 · Cited by 12
MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics
Lin, K.-H., Gómez, E. V., Corey, K. E., Connelly, M. A., Gupta, S. K., Lake, J. E., Chalasani, N., & Gawrieh, S. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02317-4 · Cited by 12
Global Health Inequities in Electrophysiology Care
Garg, K., Satti, D. I., Yadav, R., Brumfield, J., Akwanalo, C. O., Mesubi, O. O., Cooper, L. A., Nabih, M., Sogade, F., Bloomfield, G. S., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101387 · Cited by 12
Radionuclide imaging of inflammation in atherosclerotic vascular disease among people living with HIV infection: current practice and future perspective
Lawal, I. O., Ankrah, A. O., Stoltz, A. C., & Sathekge, M. M. (2019) · European Journal of Hybrid Imaging · doi:10.1186/s41824-019-0053-7 · Cited by 12
The influence of healthcare financing on cardiovascular disease prevention in people living with HIV
Webel, A. R., Schexnayder, J. K., Rentrope, C. R., Bosworth, H. B., Hileman, C. O., Okeke, N. L., Vedanthan, R., & Longenecker, C. T. (2020) · BMC Public Health · doi:10.1186/s12889-020-09896-8 · Cited by 12
Self-citation
Hypertension among adults enrolled in HIV care in northern Tanzania: comorbidities, cardiovascular risk, and knowledge, attitudes and practices
Manavalan, P., Madut, D. B., Hertz, J. T., Thielman, N. M., Okeke, N. L., Mmbaga, B. T., & Watt, M. H. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.41.285.26952 · Cited by 12
Association of HIV Infection and Incident Abdominal Aortic Aneurysm Among 143 001 Veterans
Filipkowski, A. M., Kundu, S., Eden, S., Alcorn, C., Justice, A. C., So‐Armah, K., Tindle, H. A., Wells, Q. S., Beckman, J. A., Freiberg, M. S., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.063040 · Cited by 12
Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection
Jeudy, J., Patel, P., George, N., Burrowes, S. A. B., Husson, J., Chua, J., Conn, L., Weiss, R. G., & Bagchi, S. (2021) · AIDS · doi:10.1097/qad.0000000000003125 · Cited by 12
Self-citation
Plasma CD16+Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV+Adults on Combination Antiretroviral Therapy
de Menezes, E. G. M., Deng, X., Liu, J., Bowler, S. A., Shikuma, C. M., Stone, M., Hunt, P. W., Ndhlovu, L. C., & Norris, P. J. (2022) · mBio · doi:10.1128/mbio.03005-21 · Cited by 12
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV
Daar, E. S., Orkin, C. M., Sax, P. E., Hagins, D. P., Pozniak, A., Workowski, K., Brinson, C. C., Tiraboschi, J. M., Liu, H., Deaton, C., et al. (2025) · AIDS Research and Therapy · doi:10.1186/s12981-025-00732-w · Cited by 10
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
Ndung’u, T., Dong, K. L., Colby, D. J., Deeks, S. G., Cotton, M. F., Dubé, K., Goulder, P., Jülg, B. D., Nsubuga, M. S., Ajibola, G., et al. (2026) · The Lancet HIV · doi:10.1016/s2352-3018(25)00373-x · Cited by 14
High incidence of subclinical peripheral artery disease in people with HIV
Suarez‐Zdunek, M. A., Høgh, J., Kirkegaard-Klitbo, D. M., Jensen, A. M. R., Rupert, A. W., Trøseid, M., Gerstoft, J., Nielsen, S. D., & Knudsen, A. D. (2022) · AIDS · doi:10.1097/qad.0000000000003252 · Cited by 11
Predictors of subclinical atherosclerosis in HIV
Soto, J. F., Romero-Jiménez, M. J., García, J. C. A., Estruch, E. B., Sánchez‐Ramos, J. L., & López, M. Á. C. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-022-07976-1 · Cited by 10
Serum Lipid Profiles, Blood Glucose, and High-Sensitivity C-Reactive Protein Levels Among People Living with HIV Taking Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy at Jimma University Medical Center, Southwest Ethiopia, 2021
Waritu, N. C., Nair, S. K. P., Birhan, B., Adugna, T., Awgichew, G. B., & Jemal, M. (2024) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s430310 · Cited by 11
The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis
Wei, J., Hui, W., Fang, Y., Jia, H., Yu, Y. W., Zhang, T., Wu, H., Su, B., & Jiang, T. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10455-y · Cited by 11
Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?
Okeke, N. L., Schafer, K. R., Meissner, E. G., Ostermann, J., Shah, A., Ostasiewski, B., Phelps, E., Kieler, C. A., Oladele, E., Garg, K., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa361 · Cited by 11
Self-citation
Patients Living With HIV Are Less Likely to Receive Appropriate Statin Therapy for Cardiovascular Disease Risk Reduction
Emmons, R. P., Hastain, N. V., Miano, T. A., & Schafer, J. J. (2022) · Journal of Pharmacy Practice · doi:10.1177/0897190021999790 · Cited by 11
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study
Schoepf, I. C., Thorball, C. W., Kovari, H., Ledergerber, B., Buechel, R. R., Calmy, A., Weber, R. K., Kaufmann, P. A., Nkoulou, R. N., Schwenke, J. M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac758 · Cited by 11
GLP ‐1 agonists for people living with HIV and obesity, is there a potential?
Zino, L., Tack, C. J., Richel, O., & Burger, D. M. (2023) · HIV Medicine · doi:10.1111/hiv.13521 · Cited by 12
Hypertension Among Cohort of Persons With Human Immunodeficiency Virus Initiated on a Dolutegravir-Based Antiretroviral Regimen in Ghana
Lartey, M. Y., Torpey, K., Ganu, V. J., Addo, S. A., Bandoh, D. A., Abdulai, M., Akuffo, G. A., & Kenu, E. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae061 · Cited by 11
Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial
Takada, S., Ober, A. J., Currier, J. S., Goldstein, N. J., Horwich, T. B., Mittman, B. S., Shu, S. B., Tseng, C., Vijayan, T., Wali, S., et al. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.02.012 · Cited by 11
Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
Boettiger, D. C., Newall, A. T., Phillips, A. N., Bendavid, E., Law, M. G., Ryom, L., Reiss, P., Mocroft, A., Bonnet, F., Weber, R. K., et al. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25690 · Cited by 11
Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long‐Term Antiretroviral Suppressive Therapy (EVERLAST) Study
Sarfo, F., Norman, B., Appiah, L., & Ovbiagele, B. (2021) · The Journal of Clinical Hypertension · doi:10.1111/jch.14255 · Cited by 10
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
Douglas, P. S., McCallum, S., Lu, M. T., Umbleja, T., Fitch, K. V., Foldyna, B., Zanni, M. V., Fulda, E. S., Bloomfield, G. S., Fichtenbaum, C. J., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003418 · Cited by 11
Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy
Kettelhut, A., Bowman, E., Gabriel, J., Hand, B. N., Liyanage, N. P. M., Kulkarni, M., Avila-Soto, F., Lake, J. E., & Funderburg, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.879600 · Cited by 10
Patient and provider perspectives on barriers to myocardial infarction care among persons with human immunodeficiency virus in Tanzania: A qualitative study
Prattipati, S., Tarimo, T. G., Kweka, G. L., Mlangi, J. J., Samuel, D. R., Sakita, F. M., Tupetz, A., Bettger, J. P., Thielman, N. M., Temu, G. A., et al. (2023) · International Journal of STD & AIDS · doi:10.1177/09564624231199507 · Cited by 10
Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial
Zou, R. S., Ruan, Y., Truong, B. M. T., Bhattacharya, R., Lu, M. T., Karády, J., Bernardo, R. C., Finneran, P., Hornsby, W., Fitch, K. V., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033413 · Cited by 10
Single-Cell Analysis of Subcutaneous Fat Reveals Profibrotic Cells That Correlate With Visceral Adiposity in HIV
Bailin, S. S., Gabriel, C. L., Gangula, R., Hannah, L., Nair, S., Carr, J. J., Terry, J. G., Silver, H. J., Simmons, J. D., Mashayekhi, M., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae369 · Cited by 10
The triglyceride-glucose index trajectories are associated with cardiovascular diseases in people living with HIV: evidence from a prospective cohort study in China, 2005–2022
Luo, Y., Sun, L., He, Y., Zhao, F., Shan, D., Bu, F., Ge, L., Li, X., Hu, Y., Xiao, X., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-21744-1 · Cited by 10
Dyslipidemia and statin use in people with HIV-1 infection: beyond the lipid-lowering effect
Gazzaniga, G., Ridolfi, M., Lazzaro, A., Brogi, T., Pignatelli, P., Pastori, D., & Mezzaroma, I. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104110 · Cited by 10
HIV-Tat and vascular endothelium: implications in the HIV associated brain, heart, and lung complications
Sivasankar, C., Adler, M., Chen, L., Kaur, S., & Dhillon, N. K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1621338 · Cited by 9
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics
Boccara, F., Kumar, P. N., Caramelli, B., Calmy, A., López, J. A. G., Bray, S. L., Cyrille, M., & Rosenson, R. S. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.11.004 · Cited by 10
Developing a pilot lifestyle intervention to prevent cardiovascular disease in midlife women with HIV
Raggio, G. A., Goodman, G. R., Robbins, G. K., Looby, S. E. D., Labbe, A. K., & Psaros, C. (2021) · HIV Research & Clinical Practice · doi:10.1080/25787489.2021.1883957 · Cited by 10
Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus
Lake, J. E., Wang, R., Barrett, B. W., Bowman, E., Hyatt, A. N., Debroy, P., Candelario, J., Teplin, L. A., Bodnar, K., McKay, H., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003346 · Cited by 11
Incidence and risk factors of hypertriglyceridemia in males with human immunodeficiency virus who are treated with combination antiretroviral therapy: a retrospective cohort study
Yu, X.-D., Huang, H., Jiao, Y., Li, J., Fan, X., Zhang, D., & Wang, F. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01786-3 · Cited by 10
Hypertension among persons living with HIV—Zambia, 2021; A cross-sectional study of a national electronic health record system
Hines, J. Z., Prieto, J. T., Itoh, M., Fwoloshi, S., Zyambo, K., Sivile, S., Mweemba, A., Chisemba, P., Kakoma, E., Zachary, D., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001686 · Cited by 10
Correlates of physical activity among people living with and without HIV in rural Uganda
Mabweazara, S. Z., Manne‐Goehler, J., Bibangambah, P., Kim, J., Sentongo, R. N., Hemphill, L., Okello, S., Hamer, M., & Siedner, M. J. (2023) · Frontiers in Reproductive Health · doi:10.3389/frph.2023.1093298 · Cited by 10
Potentially Inappropriate Prescribing in Older People Living With HIV: A Scoping Review
Vélez‐Díaz‐Pallarés, M., Delgado-Silveira, E., Fradejas, J. F., Montero-Llorente, B., Palomar-Fernández, C., Montero‐Errasquín, B., Cruz-Jentoft, A. J., & Álvarez‐Díaz, A. M. (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003298 · Cited by 11
Cytomegalovirus Infection Facilitates the Costimulation of CD57+CD28− CD8 T Cells in HIV Infection and Atherosclerosis via the CD2–LFA-3 Axis
Winchester, N., Panigrahi, S., Haria, A., Chakraborty, A., Su, X., Chen, B., Morris, S. R., Clagett, B. M., Juchnowski, S. M., Yadavalli, R., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300267 · Cited by 10
Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
Boettiger, D. C., Newall, A. T., Chattranukulchai, P., Chaiwarith, R., Khusuwan, S., Avihingsanon, A., Phillips, A. N., Bendavid, E., Law, M. G., Kahn, J. G., et al. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25494 · Cited by 10
Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus
Tan, B. K., Chalouni, M., Salmon, D., Cinaud, A., Esterle, L., Loko, M., Katlama, C., Poizot‐Martin, I., Neau, D., Chas, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1014 · Cited by 10

Authors: Shah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., Rajagopalan, S., Kottilil, S., Nair, H., Newby, D. E., McAllister, D. A., & Mills, N. L.
Affiliations: University of Edinburgh (GB)
Joint United Nations Programme on HIV/AIDS (CH)
Case Western Reserve University (US)
University of Maryland, Baltimore (US)
University of Glasgow (GB)
ORCID: Shah, Anoop S.V.
Stelzle, Dominik
Lee, Kuan Ken
Beck, Eduard J.
Alam, Shirjel
Longenecker, Chris T.
Strachan, Fiona
Bagchi, Shashwatee
Whiteley, William
Rajagopalan, Sanjay
Kottilil, Shyamasundaran
Nair, Harish
Newby, David E.
McAllister, David A.
Mills, Nicholas L.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2018-09-11
Volume: 138
Issue: 11
Pages: 1100-1112
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.117.033369
PMC: PMC6221183
OpenAlex: W3025713364
Cited by: 975
References: 60
Citations by year: 2026: 139 · 2025: 153 · 2024: 159 · 2023: 117 · 2022: 137 · 2021: 111 · 2020: 99 · 2019: 51 · 2018: 8
FWCI: 82.17
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders: Wellcome Trust (201492/Z/16/Z)
British Heart Foundation (FS/18/25/33454, FS/16/14/32023)
University of Glasgow
Topics: Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: HIV-associated cardiovascular disease, atherosclerotic cardiovascular disease, global burden of disease, disability-adjusted life years, population attributable fraction, people living with HIV, antiretroviral therapy, sub-Saharan Africa, cardiovascular risk, non-communicable diseases, cardiovascular risk factors
MeSH terms: Adult, Female, Humans, Male, Middle Aged, Prognosis, Risk Factors, Time Factors, Global Health, HIV Infections, Incidence, Prevalence, Cost of Illness, Risk Assessment, HIV Long-Term Survivors, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks